CEACAM5 antibody
Quick Overview for CEACAM5 antibody (ABIN356455)
Target
See all CEACAM5 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- This antibody recognizes CEA in several tumor tissues. Cellular localization: Luminal membrane and Cytoplasmic.
-
Purification
- Ig Fraction
-
Immunogen
- Human CEA purified from colon carcinoma.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Immunohistochemistry for formalin-Fixed Paraffin Embedded (FFPE) Tissue Sections andFrozen Sections: Dilute 1/100-1/200 using polymer or streptavidin approx. biotin system for 30 mins at room temperature. Positive control: Human colon cancer.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 2.0 mg/mL
-
Buffer
- 10 mM PO4, 150 mM NaCl, pH 7.4 containing 0.05 % Sodium Azide as preservative.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
-
-
- CEACAM5 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5))
-
Alternative Name
- CD66e / CEACAM5
-
Background
- CEA is highly glycosylated 180 kDa glycoprotein involved in cell adhesion. It is normally produced during fetal development and then re expressed in increased amounts in colorectal, gastric, pancreatic, lung and breast carcinomas. CEA measurement is mainly used as tumor marker to identify recurrence after surgical resection.Synonyms: CEA, Carcinoembryonic antigen, Carcinoembryonic antigen-related cell adhesion molecule 5, Meconium antigen 100
-
Gene ID
- 1048
-
NCBI Accession
- NP_004354
-
UniProt
- P06731
Target
-